Latest INOVIO Pharmaceuticals News & Updates

See the latest news and media coverage for INOVIO. We track all announcements, press releases, and industry mentions in real time, all in one place.

INOVIO Pharmaceuticals (INOVIO)

Biotechnology company developing DNA-based medicines

inovio.com

Headquarters: Plymouth Meeting, United States
Company type: Public company
Number of employees: 200–210
Industry: Biotechnology & Medical Research

Last updated Yesterday

Latest news about INOVIO Pharmaceuticals (INOVIO)

In short: INOVIO secured FDA accelerated approval for VOCERYQ and expected to begin shipping in about 60 days.

Company announcements

October 30 INOVIO

INOVIO wins FDA accelerated approval for RRP immunotherapy

The plasmid DNA-based treatment reduces the frequency of surgery in adults with recurrent respiratory papillomatosis, a rare HPV-related disease. A webcast is set for Monday, November 2.

October 5 INOVIO

INOVIO attends Oxford Global conference in San Diego

The company joins global experts on October 12th to discuss drug discovery and next-generation DNA medicine for rare disease.

October 1 INOVIO

INOVIO highlights BRCA cancer prevention trial with Penn Medicine

Researchers are testing whether an INOVIO DNA medicine can help people with BRCA1 and BRCA2 mutations by detecting early disease signs and stopping breast cancer before it develops.

August 12 INOVIO

INOVIO reports second quarter 2026 financial results

The company also shares operational highlights for the quarter.

Media coverage

Yesterday Ad Hoc News

Inovio Pharmaceuticals stock: VOCERYQ shipment in about 60 days

Inovio Pharmaceuticals is focusing on the commercialization of VOCERYQ following the accelerated approval granted yesterday. The company expects orders and shipments in approximately 60...

October 30 Reuters

US FDA approves Inovio s treatment for rare throat disease; shares surge

The US Food and Drug Administration on Friday approved Inovio Pharmaceuticals' treatment for a rare...

October 29 American City Business Journals

After $80M court judgment, Inovio could get even better news from the FDA

Inovio Pharmaceuticals was awarded $80 million in a breach of contract lawsuit tied to its unsuccessful Covid-19 vaccine effort.

October 28 RTTNews

Inovio Awaits FDA Decision On INO-3107 For Rare Respiratory Disease

Inovio Pharmaceuticals is approaching a key regulatory milestone as the U.S. FDA is scheduled to decide on the company's Biologics License Application for INO-3107 by...

Never miss news about INOVIO

Track INOVIO and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

INOVIO competitors & trending companies

Browse news for competitors to INOVIO and other trending companies.